Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5510
-0.0232-4.04%
Last update: Jan 13, 10:52 AM
Comments
Loading...
Outlook Therapeutics (OTLK) Stock Price, Quote, News & History
OTLKNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Who are Outlook Therapeutics (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Kyntra Bio Inc (NASDAQ:KYNB), Galecto Inc (NASDAQ:GLTO), Estrella Immunopharma Inc (NASDAQ:ESLA), Barinthus Biotherapeutics PLC (NASDAQ:BRNS) and Cue Biopharma Inc (NASDAQ:CUE).
What is the forecast, or price target, for Outlook Therapeutics (OTLK) stock?
Outlook Therapeutics has a consensus price target of $4.01.
What is the current price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $0.551 last updated January 13, 2026 at 10:52 AM EST.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics does not have any upcoming earnings scheduled.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
